The sold production of oxygen-function amino-compounds, except lysine and glutamic acid, in Germany is forecasted to grow from 623.37 million euros in 2024 to 657.24 million euros in 2028. This indicates a gradually increasing trend. Comparing year-on-year, there is an incremental growth rate from 2024 to 2028. The compound annual growth rate (CAGR) over these five years reflects a steady, moderate increase.
For future trends, watch for:
- Innovation in biochemical processes that could reduce production costs.
- Fluctuations in raw material prices impacting production value.
- Changes in environmental regulations that may affect industry practices.